2Ryffel B,Brockhaus M,Greiner B,et al.Tumour necrosis factor receptor distribution in human lymphoid tissue.Immunology,1991,74:446-452.
3Hohmann H P,Remy R,Brockhaus M,et al.Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha).J Biol Chem,1989,264:14927-14934.
4Vandenabeele P,Declercq W,Vanhaesebroeck B,et al.Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells.J Immunol,1995,154:2904-2913.
5WhitesideT L,Rabinowich H.The role of Fas/FasL in immunosuppression induced by human tumors.Cancer Immunol Immunother,1998,46:175-184.
6Zhang X D,Franco A,Myers K,et al.Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.Cancer Res,1999,59:2747-2753.
7Zhang X D,Franco A V,Nguyen T,et al.Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.J Immunol,2000,164:3961-3970.
8Ashkenazi A,Pai R C,Fong S,et al.Safety and antitumor activity of recombinant soluble Apo2 ligand.J Clin Invest,1999,104:1551-1562.
9Frank S,Kohler U,Schackert G,et al.Expression of TRAIL and its receptors in human brain tumors.Biochem Biophys Res Commun,1999,257:454-459.
3[1]Hohmann HP,Remy R,Brockhaus M,et al.Two different cell types have different major recepors for human tumor necrosis factor(TNF)[J].J Biol Chem,1989,264:14927-14934.
4[2]Tartaglia LA,Ayres TM,Wong GHW,et al. A novel domain within the 55 kD TNF receptor signals cell death[J]. Cell,1993,74:845-853.
5[3]Barbara JAJ,Smith WB,Gamble JR,et al.Dissociation of TNFα cytotoxic and proinflammatory activities by p55 receptor and p75 receptor-selective TNFα mutants[J].EMBO J,1994,13:843-850.
6[4]Loetscher H,Pan YCE,Lahm HW,et al. Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor[J]. Cell,1990,61:351-359.
7[5]Schall TJ,Lewis M,Koller KJ,et al. Molecular cloning and expression of a receptor for human tumor necrosis factor[J]. Cell,1990,61:362-370.
8[7]Tsutomu S,Yamauchi N,Sasaki N,et al. An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55 kD tumor necrosis factor(TNF) receptor gene transfection and mutein TNF administration[J]. Cancer Res,1998,58:1677-1683.
9[8]Isobe K,Fan Z H,Emi N,et al. Gene transfer of TNF receptor for treatment of cancer by TNF[J].Biochem and Biophy Res Commmuni,1994,202:1538-1542.
3Yamaguchi Y, Ohta K, Shimizu K, et al. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2[J]. Anticancer Res, 2001 , 21(1B) :669-677.
4Whiteside T L, Miescner S, MacDonald H R, et al. Separation of tumor-infiltrating lymphocytes from cells in human solid tumor. A comparison between velocity sedimentation and discontimuous density gradients[J]. J Immunal Methods, 1996, 90 (1) :221-224.
5Itoh Y, Kohgo Y, Matanabe N, et al. Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells[J]. Jpn J Cancer, 1991, 82(11) :1203-1206.
6Hohmann H P, Remy R, Brockhaus M, et al. Two different cell types have different major receptors for human tumor necro- sis factor (TNF alpha) [J]. J Biol Chem, 1989, 264 (25).. 14927-14934.
7Sehutze S, Maehleidt T, Kronke M, et al. Mechanisms of tumor necrosis factor aetion[J]. Semin Oneol, 1992, 19(2 Suppl 4): 16-24.
8Sato Y, Koshita Y, Hirayama M, et al. Augmented antitumor effects of killer cells induced by tumor necrosis factor gene- transduced autologous tumor cells from gastrointestinal cancer patients[J]. Hum Gene Tther, 1996, 7(15): 1895-1905.
